Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C036535 |
1,6-bis(cyclohexyloximinocarbonyl)hexane |
1,6-bis(cyclohexyloximinocarbonyl)hexane results in decreased activity of DAGLB protein | decreases activity | 18657971
|
C075809 |
1-stearoyl-2-arachidonoylglycerol |
DAGLB protein results in increased metabolism of 1-stearoyl-2-arachidonoylglycerol | increases metabolic processing | 18657971
|
C094503 |
2-arachidonylglycerol |
DAGLB protein results in increased chemical synthesis of 2-arachidonylglycerol | increases chemical synthesis | 18657971
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of DAGLB mRNA | affects expression | 17562736
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of DAGLB mRNA | increases expression | 20106945
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of DAGLB mRNA | decreases expression | 18927307
|
C104810 |
methyl arachidonylfluorophosphonate |
methyl arachidonylfluorophosphonate results in decreased activity of DAGLB protein | decreases activity | 18657971
|
C055122 |
orlistat |
orlistat results in decreased activity of DAGLB protein | decreases activity | 18657971
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of DAGLB mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of DAGLB mRNA | affects cotreatment|decreases expression | 19465110
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.08 | 15322242 11752688 14514962 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.11 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.21 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.69 | 20435547 |
MESH:D019121 |
Burkholderia Infections |
|
orlistat |
6.91 | 17874328 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
1.39 | 3084413 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 16120746 18670907 18850075 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.67 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.64 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.04 | 19486331 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.97 | 15894690 |
MESH:D002916 |
Chylothorax |
|
orlistat |
6.91 | 17003701 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 15340226 16354765 8697196 12621046 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.62 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.36 | 15273666 18259882 18509181 16391804 16303861 17159606 17454858 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 15322242 20055451 |
MESH:D048909 |
Diabetes Complications |
|
orlistat |
6.10 | 19207292 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.93 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D003967 |
Diarrhea |
|
orlistat |
4.91 | 20002075 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.42 | 11743745 19923254 18071297 16485898 11739529 17522070 17906064 19370779 18713872 16393943 12705907 11421492 14725611 14550746 16781746 12153990 16109766 19420014 14986274 17562736 16081117 12540782 10915739 2444490 11834606 10774834 11461765 12958197 19739265 11529661 11287661 12594235 19085960 15619225 15968718 19164858 16177239 12392966 19416960 10663392 16227642 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.42 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.42 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.36 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.55 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 15322242 16714409 18230668 |
MESH:D004660 |
Encephalitis |
|
2-arachidonylglycerol |
7.21 | 16364651 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.03 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.21 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.21 | 20067830 |
MESH:D005414 |
Flatulence |
|
orlistat |
6.91 | 20002075 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.94 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.46 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D016489 |
Head Injuries, Closed |
|
2-arachidonylglycerol |
7.21 | 16364651 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.41 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.66 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 8697196 16959395 15340226 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.84 | 16870215 |
MESH:D006949 |
Hyperlipidemias |
|
orlistat |
5.27 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.14 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.14 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.93 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
orlistat |
8.38 | 17201808 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
8.38 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.71 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.10 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.10 | 10903974 8314463 18776723 |
MESH:C531755 |
Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules |
|
orlistat |
6.91 | 17185156 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.88 | 12371664 |
MESH:D008103 |
Liver Cirrhosis |
|
orlistat |
4.43 | 17404856 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.66 | 19014921 16611625 19460945 12587719 19784758 12969438 16610002 11587558 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.40 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.77 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.20 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D008207 |
Lymphatic Metastasis |
|
orlistat |
6.08 | 18770866 20805790 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.24 | 14737004 |
MESH:D008545 |
Melanoma |
|
orlistat |
3.44 | 20805790 18770866 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.78 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.05 | 16801185 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.25 | 17159606 |
MESH:D009135 |
Muscular Diseases |
|
orlistat |
5.66 | 18430571 |
MESH:D009164 |
Mycobacterium Infections |
|
orlistat |
5.76 | 21442799 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.23 | 18259882 |
MESH:D009369 |
Neoplasms |
|
orlistat |
3.96 | 18710210 |
MESH:D009374 |
Neoplasms, Experimental |
|
orlistat |
5.27 | 19381703 |
MESH:D009389 |
Neovascularization, Pathologic |
|
orlistat |
5.58 | 17012255 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.71 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.44 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.56 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.01 | 18514411 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.97 | 8761367 |
MESH:C541083 |
Non-alcoholic Fatty Liver Disease |
|
orlistat |
5.73 | 17404856 |
MESH:D009765 |
Obesity |
|
orlistat |
3.79 | 18773755 21442799 20065556 19461584 19046740 20599501 16938137 21438711 20002075 20518802 19207292 20540997 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.53 | 16870215 |
MESH:D010195 |
Pancreatitis |
|
orlistat |
5.03 | 20065556 16938137 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
orlistat |
5.46 | 17201808 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.37 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.43 | 11896295 11118676 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.37 | 18760546 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.28 | 16882103 |
MESH:D012035 |
Refsum Disease |
|
orlistat |
6.31 | 20871815 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.11 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.22 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
orlistat |
3.22 | 19381703 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.16 | 10982225 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.25 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.71 | 17120751 |